Skip to main content
. 2015 Mar 5;9:1349–1358. doi: 10.2147/DDDT.S71060

Figure 4.

Figure 4

The pooled OR from eleven studies including 296 squamous cell carcinomas and 486 ADs.

Notes: OR=1.46, 95% CI=0.75–2.83, P=0.26, which indicated that CXCR4 expression does not play a big difference in the pathogenesis of SCCs and AD.

Abbreviations: AD, adenocarcinomas; CI, confidence interval; M-H, Mantel-Haenszel; NSCLC, non-small cell lung cancer; OR, odds ratio; SCCs, squamous cell carcinomas; CXCR4, chemokine receptor type 4.